The longer answer requires understanding what the April 30 notice actually says, what the June 30, 2026 comment deadline means, and the practical difference between the two compounding pathways
The mechanism behind tirzepatide, its unique dual-receptor approach , targets the very metabolic dysfunction that drives PCOS in the first place
Compounding drugs can fulfill an important purpose
Growth hormone / insulin-like growth factor-1 axis during puberty
Different administration methods for different goals: Oral or sublingual administration may be ideal for gut support and systemic effects, while injectable forms might be preferred for targeted musculoskeletal issues
For many patients who are not ready for pregnancy, long-acting reversible contraceptives such as IUDs or implants may be a more reliable option